Beam Therapeutics Correlations

BEAM Stock

USD 23.30 0.43 1.88%

The current 90-days correlation between Beam Therapeutics and Editas Medicine is 0.28 (i.e., Modest diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Beam Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Beam Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Beam Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

To learn how to invest in Beam Stock, please use our How to Invest in Beam Therapeutics guide.

Moving together with Beam Stock

0.65	DMAC	DiaMedica Therapeutics	Pair Corr
0.63	DOMH	Dominari Holdings	Pair Corr
0.64	VERV	Verve Therapeutics	Pair Corr
0.62	MNMD	Mind Medicine	Pair Corr

Moving against Beam Stock

0.5	MLEC	Moolec Science SA	Pair Corr
0.39	MLYS	Mineralys Therapeutics,	Pair Corr

Related Correlations Analysis

	EDIT	CRSP	CRBU	VERV	NTLA	FATE	PRME	VRTX	DNA	SANA
EDIT		0.77	-0.26	0.28	0.23	-0.04	0.07	0.38	-0.09	0.03	EDIT
CRSP	0.77		-0.19	0.47	0.32	0.06	0.18	0.34	0.17	0.13	CRSP
CRBU	-0.26	-0.19		0.11	0.73	0.91	0.86	-0.92	0.48	-0.07	CRBU
VERV	0.28	0.47	0.11		0.21	0.27	0.35	0.06	0.78	0.43	VERV
NTLA	0.23	0.32	0.73	0.21		0.87	0.77	-0.58	0.32	-0.28	NTLA
FATE	-0.04	0.06	0.91	0.27	0.87		0.86	-0.79	0.54	-0.17	FATE
PRME	0.07	0.18	0.86	0.35	0.77	0.86		-0.76	0.63	0.13	PRME
VRTX	0.38	0.34	-0.92	0.06	-0.58	-0.79	-0.76		-0.31	0.09	VRTX
DNA	-0.09	0.17	0.48	0.78	0.32	0.54	0.63	-0.31		0.36	DNA
SANA	0.03	0.13	-0.07	0.43	-0.28	-0.17	0.13	0.09	0.36		SANA
	EDIT	CRSP	CRBU	VERV	NTLA	FATE	PRME	VRTX	DNA	SANA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FATE	+ 0.91	CRBU
FATE	+ 0.87	NTLA
PRME	+ 0.86	CRBU
PRME	+ 0.86	FATE
DNA	+ 0.78	VERV
CRSP	+ 0.77	EDIT

High negative correlations

VRTX	- 0.92	CRBU
VRTX	- 0.79	FATE
VRTX	- 0.76	PRME
VRTX	- 0.58	NTLA
DNA	- 0.31	VRTX
SANA	- 0.28	NTLA

Risk-Adjusted Indicators

There is a big difference between Beam Stock performing well and Beam Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Beam Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EDIT	6.73	0.73	0.10	(1.10)	7.88	(8.68)	12.20	(9.27)	119.53
CRSP	2.60	0.11	0.05	0.18	2.81	(2.82)	5.26	(4.42)	19.32
CRBU	3.04	(0.82)	0.00	(35.90)	0.00	0.00	5.26	(6.86)	17.85
VERV	4.52	0.23	0.03	0.06	5.07	(4.92)	11.11	(8.25)	30.05
NTLA	3.76	(0.35)	0.00	(1.15)	0.00	0.00	7.76	(7.09)	20.66
FATE	4.62	(0.76)	0.00	(0.84)	0.00	0.00	8.48	(9.36)	22.21
PRME	4.43	(0.45)	0.00	5.12	0.00	0.00	10.03	(8.65)	25.37
VRTX	1.13	0.36	0.31	22.82	1.01	(1.29)	2.53	(2.30)	8.45
DNA	5.69	(0.16)	0.00	(0.33)	0.00	0.00	11.48	(9.86)	30.87
SANA	7.83	1.69	0.27	(0.84)	5.96	(10.82)	10.15	(10.07)	178.30

Beam Therapeutics Corporate Management

Manmohan Singh	Chief Officer	Profile
Nicole Gaudelli	CoFounder	Profile
Brian Riley	VP Operations	Profile
Susan OConnor	Chief Officer	Profile
Alexis Komor	CoFounder	Profile
Amy MD	Chief Officer	Profile
Suzanne Fleming	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC